Back to Directory Carolee Welebob Email carolee_welebob@merck.com Institution Merck Address Merck , Request an Update Affiliated Studies P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
